Voyager Therapeutics Inc (VYGR)
Voyager Therapeutics stock today
Voyager Therapeutics closed at $1.72 on October 30, 2026, down 2.27% on the day. Over the past year it returned -61.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $104 million.
| Period | VYGR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -35.8% | -0.9% |
| 3 months | -45.0% | +2.1% |
| Year to date | -56.2% | +11.7% |
| 1 year | -61.9% | +12.4% |
| 3 years | -73.7% | +88.5% |
| 5 years | -52.5% | +76.0% |
Key statistics
- Market value
- $104M
- Price / sales
- 3.0
- 52-week range
- $1.72 to $5.00
- Next report
- Nov 9, 2026 (estimated)
About Voyager Therapeutics
Develops gene therapy treatments for neurological and genetic diseases.
Sector: Health Care
More on Voyager Therapeutics
- Financials: revenue, earnings and segmentsRevenue -50% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $140.98 today
No forecast, no recommendation. This page describes Voyager Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.